期刊文献+

奥美拉唑和泮托拉唑治疗消化道溃疡的成本-效果分析

Omeprazole and pantoprazole in the treatment of peptic ulcer of the cost-effectiveness analysis
暂未订购
导出
摘要 目的对奥美拉唑和泮托拉唑治疗消化道溃疡进行药物经济学分析,为临床合理用药提供参考方案。方法采用统计学研究和成本-效果分析方法 ,将我院100例良性消化道溃疡患者,随机分为A组及B组,A组给予奥美拉唑,B组给予泮托拉唑,比较两组的成本-效果及不良反应。结果两组总有效率分别为94%和96%,效果无显著差异(P>0.05),治疗成本分别为523.00元和445.20元,差异显著(P<0.05),进行敏感度分析,结果仍相符。两组不良反应均以胃肠道反应为主。结论 B组成本-效果较好,从经济学角度考虑,B组比A组更经济合理。 Objective Omeprazole and pantoprazole for treatment of peptic ulcer drugs,economic analysis,provide a reference for the clinical program of rational drug use. Methods The statistical studies and cost -effectiveness analysis,will be in our hospital 100 cases of benign ulcer were randomly divided into A group and B group,A group received omeprazole,B group received pantoprazole,compare the cost of the two groups -and adverse response. Results The total effective rate were 94% and 96% ,there were no significant difference ( P 0. 05) ,treatment costs were 523. 00 yuan and 445. 20 yuan,there were significan difference ( P 0. 05) ,the sensitivity analysis,the results still consistent. Two groups of adverse reactions were gastrointestinal reactions. Conclusion B group have a good cost effectveness. From the economic point of view,B group than in the A group is more economical.
作者 曹丽
出处 《中国现代药物应用》 2010年第21期15-16,共2页 Chinese Journal of Modern Drug Application
关键词 泮托拉唑 奥美拉唑 消化性溃疡 成本-效果 Pantoprazole Omeprazole Peptic ulcer Cost -effectiveness
  • 相关文献

参考文献4

二级参考文献35

  • 1黄淑勤,樊庆鲜.奥美拉唑和阿莫西林治疗幽门螺杆菌相关性十二指肠溃疡的疗效观察[J].医学文选,2005,24(5):720-722. 被引量:6
  • 2李尚勤,孟丽秋.功能性消化不良与幽门螺杆菌感染的相关性研究[J].医学综述,2005,11(10):952-953. 被引量:20
  • 3刘文忠.幽门螺杆菌感染与功能性消化不良[J].临床消化病杂志,2006,18(2):72-74. 被引量:50
  • 4[2]Axon AT.Helicobacter pylori therapy:effect on peptic ulcer disease[J].J Gastroenterol Hepatol,1991,16(2):131-137.
  • 5Talley N J, Vakil N B, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia [J]. Gastroenterology, 2005,129: 1756-1780.
  • 6Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R,Megraud F. Risk factors for failure of Helicobacter pylori therapy-resuhs of an individual data analysis of 2 751 patients [J]. Aliment Pharmacol Ther,2003,17:99-109.
  • 7Francavilla R, Lionetti E. Castellaneta S P, Magist A M, Boscarelli G,Piscitelli D,et al. Improved efficacy of 10 Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial[ J ]. Gastroenterology, 2005,129 : 1414- 1419.
  • 8Zullo A,Gatta L,De Francesco V, Hassan C,Ricci C,Berna bucci V, et al. High rate of Helieobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a pro spective controlled study[J]. Aliment Pharmacol Ther.2005, 21:1419-1424.
  • 9Scaccianoee G. Hassan C, Panarese A, Piglionica D. Morini S, Zullo A. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen [J]. Can J Gastroenterol,2006,20:113-117.
  • 10De Francesco V, Margiotta M. Zullo A, Hassan C, Troiani L, Burattini O,et al. Clarithromycin-resistant genotypes and eradi cation of Helicobacter pylori[J]. Ann Intern Med,2006,144: 94-100.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部